CIK 0001907223 · Biological Products, (No Diagnostic Substances) (SIC 2836) · Nasdaq, Nasdaq · fiscal year ends 12/31
| FY2024 | FY2023 | |
|---|---|---|
| Net income (USD) | -707458 | 1.2 M |
| Diluted EPS (USD/shares) | -0.05 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-05 | 4 | PRIMARY DOCUMENT | 2026-10-01 |
| 2026-10-02 | 8-K | CURRENT REPORT items 5.02,9.01 | 2026-09-28 |
| 2026-10-01 | 144 | 144 | |
| 2026-09-28 | 424B5 | PROSPECTUS SUPPLEMENT | |
| 2026-09-28 | 8-K | CURRENT REPORT items 1.01,9.01 | 2026-09-23 |
| 2026-09-23 | 424B5 | PROSPECTUS SUPPLEMENT | |
| 2026-09-23 | 8-K | CURRENT REPORT items 1.01,9.01 | 2026-09-21 |
| 2026-09-23 | 424B5 | PROSPECTUS SUPPLEMENT | |
| 2026-09-11 | 8-K | CURRENT REPORT items 5.02,9.01 | 2026-09-08 |
| 2026-09-04 | 8-K | CURRENT REPORT items 1.01,2.01,3.02,5.03,5.07,9.01 | 2026-09-01 |
| 2026-09-02 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-08-27 | 8-K | CURRENT REPORT items 1.01,7.01,9.01 | 2026-08-26 |
| 2026-08-27 | 424B5 | PROSPECTUS SUPPLEMENT | |
| 2026-08-25 | 424B5 | PROSPECTUS SUPPLEMENTAL | |
| 2026-08-25 | 4 | PRIMARY DOCUMENT | 2026-08-25 |
| 2026-08-24 | 8-K | CURRENT REPORT items 1.01,9.01 | 2026-08-24 |
| 2026-08-24 | 424B5 | PROSPECTUS SUPPLEMENT | |
| 2026-08-17 | 10-Q | QUARTERLY REPORT | 2026-06-30 |
| 2026-08-14 | 10-Q/A | AMENDMENT NO. 1 TO FORM 10-Q/A | 2026-03-31 |
| 2026-08-14 | 10-K/A | AMENDMENT NO. 1 TO FORM 10-K | 2025-12-31 |
| 2026-08-14 | NT 10-Q | NOTIFICATION OF LATE FILING | 2026-06-30 |
| 2026-08-10 | 8-K | CURRENT REPORT items 5.07,9.01 | 2026-08-07 |
| 2026-07-23 | 4 | PRIMARY DOCUMENT | 2026-07-22 |
| 2026-07-23 | 8-K | CURRENT REPORT items 1.01,3.03,8.01,9.01 | 2026-07-22 |
| 2026-07-23 | 8-A12B | FOR REGISTRATION OF CERTAIN CLASSES |
Forms on file (last 1,000): 8-K 79, 4 26, CORRESP 15, 10-Q 14, 425 13, UPLOAD 11, NT 10-Q 9, 424B5 8. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=GRML (0.002 USD), /gw/filings/filings?ticker=GRML&form=8-K, /gw/filings/facts?ticker=GRML&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange